1 results match your criteria: "Clinical Research Center of Hainan Provincial Hospital of Traditional Chinese Medicine[Affiliation]"
The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome.
Evid Based Complement Alternat Med
November 2022
Clinical Research Center of Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou, China.
Objective: Based on a retrospective cohort study, to investigate the value of rivaroxaban combined with ticagrelor in antithrombotic therapy after PCI in patients with nonvalvular atrial fibrillation with acute coronary syndrome.
Methods: A total of 60 patients from January 2019 to May 2021 accepted therapy with antithrombotic therapy after PCI. The patients treated with ticagrelor were set as the control group, and those given rivaroxaban combined with ticagrelor were set as the research group.